Greenough WT - Search Results

1

Open-label riluzole in fragile X syndrome.

Erickson CA, Weng N, Weiler IJ, Greenough WT, Stigler KA, Wink LK, McDougle CJ. Erickson CA, et al. Among authors: greenough wt. Brain Res. 2011 Mar 22;1380:264-70. doi: 10.1016/j.brainres.2010.10.108. Epub 2010 Nov 5. Brain Res. 2011. PMID: 21059347 Clinical Trial.

2

Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.

Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, Weiler IJ, Greenough WT. Berry-Kravis E, et al. Among authors: greenough wt. J Dev Behav Pediatr. 2008 Aug;29(4):293-302. doi: 10.1097/DBP.0b013e31817dc447. J Dev Behav Pediatr. 2008. PMID: 18698192 Clinical Trial.

3

Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome.

Kim SH, Markham JA, Weiler IJ, Greenough WT. Kim SH, et al. Among authors: greenough wt. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4429-34. doi: 10.1073/pnas.0800257105. Epub 2008 Mar 10. Proc Natl Acad Sci U S A. 2008. PMID: 18332424 Free PMC article.

4

Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome.

Weng N, Weiler IJ, Sumis A, Berry-Kravis E, Greenough WT. Weng N, et al. Among authors: greenough wt. Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1253-7. doi: 10.1002/ajmg.b.30765. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 18452182

5

Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond.

Grossman AW, Aldridge GM, Weiler IJ, Greenough WT. Grossman AW, et al. Among authors: greenough wt. J Neurosci. 2006 Jul 5;26(27):7151-5. doi: 10.1523/JNEUROSCI.1790-06.2006. J Neurosci. 2006. PMID: 16822971 Free PMC article. Review.

6

A converging-methods approach to fragile X syndrome.

Churchill JD, Grossman AW, Irwin SA, Galvez R, Klintsova AY, Weiler IJ, Greenough WT. Churchill JD, et al. Among authors: greenough wt. Dev Psychobiol. 2002 Apr;40(3):323-38. doi: 10.1002/dev.10036. Dev Psychobiol. 2002. PMID: 11891642 Review.

7

Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.

Churchill JD, Beckel-Mitchener A, Weiler IJ, Greenough WT. Churchill JD, et al. Among authors: greenough wt. Microsc Res Tech. 2002 May 1;57(3):156-8. doi: 10.1002/jemt.10062. Microsc Res Tech. 2002. PMID: 12112451

8

Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination.

Weiler IJ, Greenough WT. Weiler IJ, et al. Among authors: greenough wt. Am J Med Genet. 1999 Apr 2;83(4):248-52. doi: 10.1002/(sici)1096-8628(19990402)83:4<248::aid-ajmg3>3.0.co;2-1. Am J Med Genet. 1999. PMID: 10208156

9

Morphogenesis in memory formation: synaptic and cellular mechanisms.

Weiler IJ, Hawrylak N, Greenough WT. Weiler IJ, et al. Among authors: greenough wt. Behav Brain Res. 1995 Jan 23;66(1-2):1-6. doi: 10.1016/0166-4328(94)00116-w. Behav Brain Res. 1995. PMID: 7755880 Review.

10

Synapse-activated protein synthesis as a possible mechanism of plastic neural change.

Weiler IJ, Wang X, Greenough WT. Weiler IJ, et al. Among authors: greenough wt. Prog Brain Res. 1994;100:189-94. doi: 10.1016/s0079-6123(08)60785-2. Prog Brain Res. 1994. PMID: 7938518 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page